Andreas Halvorsen acquired 10.5 Million Biomarin Pharmaceutical - Registered Shares shares worth $629 Million. That's 2.05% of their equity portfolio (17th largest holding). The investor owns 5.29% of the outstanding Biomarin Pharmaceutical - Registered Shares stock. The first Biomarin Pharmaceutical - Registered Shares trade was made in Q1 2016. Since then Andreas Halvorsen bought shares twenty more times and sold shares on nine occasions. The investor's estimated purchase price is $890 Million, resulting in a loss of 29%.